About Us

Pharma-Lock was founded by Mark Ventresco. Mark grew up in Massachusetts and witnessed the severity of the opioid epidemic firsthand, which was the catalyst for creating the Pharma-Lock.

Mark, obtained a master’s degree in plastics engineering from UMass Lowell. He then invented the Pharma-Lock Cap followed by several other products. The Pharma-Lock product line serve to prevent opioid abuse and prevent accidental and intentional misuse of prescription pharmaceuticals. Join us in our mission to make your home a safer place.

 

Competitions That We Have Participated In:

 
image.jpg
image.jpg
image.png
 
 

Pitch Tank

 
20180124_msd_0723.jpg
 

Medical Specialties Distributors (MSD) held their second annual Healthcare Innovation & Technology Conference, Better Together, January 22-26 at the Fontainebleau Hotel in Miami Beach, Florida. With over 600 attendees, the Better Together Conference set the landscape for post-acute healthcare providers, manufacturers, executives, technology professionals, and industry thought leaders to engage in discussions and generate actionable insights that impact the future of healthcare. 

 

M2D2

 
IMG-1866.JPG
 

The $200K Challenge is an annual start-up competition hosted by M2D2 focused on identifying and rewarding disruptive companies in the medical technology and biotechnology industries.

Up to 20 finalists become eligible to win a share of our $200,000 purse of sponsor-provided, in-kind services. These services include lab and office space; engineering, product development, legal, regulatory, clinical, and business services. Past winners have been empowered to bring their innovations to life - and to market.


MARK VENTRESCO

Founder & CEO

Mark Ventresco has an educational background in chemical and plastic engineering. He has experience in the medical device & pharmaceutical industries working in research and development for fortune 500 companies. He has also taken a personal life goal to improve patient's medication experience and reduce harm caused by non-adherence to prescription pharmaceuticals.